G1 Therapeutics raises $12.5 million in series A

G1 Therapeutics Inc. (Chapel Hill, N.C.) raised $12.5 million in a series A round led by new investor MedImmune Ventures. New investor Mountain Group Capital and existing investor Hatteras Venture Partners also participated. MedImmune's Michael Gutch and Ron Laufer joined G1's board. ...